Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Todd Neale

September 26, 2025

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Todd Neale

July 31, 2025

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Industry News

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

May 16, 2016

News Industry News

CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN

March 17, 2016

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

L.A. McKeown

November 08, 2015

News Industry News

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

August 31, 2015

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Conference News AHA 2012

RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation

Jason Kahn

November 06, 2012

Advertisement

New ACC Consensus Document Helps Clinicians Navigate Issues Around TR

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Failed MitraClip Is Uncommon, but Bleak When It Happens

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content